Bhavesh Patel V - 31 Mar 2022 Form 4 Insider Report for HALLIBURTON CO (HAL)

Role
Director
Signature
/s/ Bruce A. Metzinger, by Power of Attorney
Issuer symbol
HAL
Transactions as of
31 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Apr 2022, 16:59:29 UTC
Previous filing
04 Jan 2022
Next filing
05 Jul 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HAL Common Stock 10,000 31 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAL Stock Equivalent Units Award +394 +8.8% 4,873 31 Mar 2022 Common Stock 394 Direct F1, F2, F3, F4
holding HAL 12/2021 Restricted Stock Units 7,874 31 Mar 2022 Common Stock 7,874 Direct F5, F6, F7
holding HAL 03/2021 Restricted Stock Units 7,867 31 Mar 2022 Common Stock 7,867 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The security converts to common stock on a one-for-one basis.
F2 Stock equivalents acquired under the Halliburton Company Directors' Deferred Compensation Plan reported on a pro-rata basis to reflect Issuer's Plan quarter. Said Plan is an ongoing securities acquisition plan.
F3 The stock equivalent units were accrued under the Company's Directors' Deferred Compensation Plan and are settled in the Company's common stock following cessation as a director.
F4 A portion of the stock equivalents are attributable to quarterly dividends and a portion are attributable to quarterly fees and are based on the closing price on March 23, 2022 of $38.07 and March 31, 2022 of $38.87.
F5 Each restricted stock unit represents a right to receive one share of the Company's common stock.
F6 The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director.
F7 Includes dividend equivalent units through March 31, 2022.